BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24261894)

  • 1. Flavaglines: potent anticancer drugs that target prohibitins and the helicase eIF4A.
    Basmadjian C; Thuaud F; Ribeiro N; Désaubry L
    Future Med Chem; 2013 Dec; 5(18):2185-97. PubMed ID: 24261894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavaglines as natural products targeting eIF4A and prohibitins: From traditional Chinese medicine to antiviral activity against coronaviruses.
    Nebigil CG; Moog C; Vagner S; Benkirane-Jessel N; Smith DR; Désaubry L
    Eur J Med Chem; 2020 Oct; 203():112653. PubMed ID: 32693294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Aminomethyl SAR in a novel series of flavagline-inspired eIF4A inhibitors: Effects of amine substitution on cell potency and in vitro PK properties.
    Nilewski C; Michels TD; Packard GK; Xiang AX; Sprengeler PA; Eam B; Fish S; Thompson PA; Wegerski CJ; Nevarez A; Clarine J; Sperry S; Ernst JT; Reich SH
    Bioorg Med Chem Lett; 2021 Sep; 47():128111. PubMed ID: 34353608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative phytochemistry of flavaglines (= rocaglamides), a group of highly bioactive flavolignans from
    Greger H
    Phytochem Rev; 2022; 21(3):725-764. PubMed ID: 34104125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP-competitive, marine derived natural products that target the DEAD box helicase, eIF4A.
    Tillotson J; Kedzior M; Guimarães L; Ross AB; Peters TL; Ambrose AJ; Schmidlin CJ; Zhang DD; Costa-Lotufo LV; Rodríguez AD; Schatz JH; Chapman E
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4082-4085. PubMed ID: 28757063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products.
    Shen L; Pelletier J
    Nat Prod Rep; 2020 May; 37(5):609-616. PubMed ID: 31782447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavaglines as potent anticancer and cytoprotective agents.
    Ribeiro N; Thuaud F; Bernard Y; Gaiddon C; Cresteil T; Hild A; Hirsch EC; Michel PP; Nebigil CG; Désaubry L
    J Med Chem; 2012 Nov; 55(22):10064-73. PubMed ID: 23072299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular approaches towards development of purified natural products and their structurally known derivatives as efficient anti-cancer drugs: current trends.
    Saha SK; Khuda-Bukhsh AR
    Eur J Pharmacol; 2013 Aug; 714(1-3):239-48. PubMed ID: 23819913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of eukaryotic translation initiation by the marine natural product pateamine A.
    Low WK; Dang Y; Schneider-Poetsch T; Shi Z; Choi NS; Merrick WC; Romo D; Liu JO
    Mol Cell; 2005 Dec; 20(5):709-22. PubMed ID: 16337595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoxazoline containing natural products as anticancer agents: a review.
    Kaur K; Kumar V; Sharma AK; Gupta GK
    Eur J Med Chem; 2014 Apr; 77():121-33. PubMed ID: 24631731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of 3,3'-pyrrolidinyl-spirooxindoles as cardioprotectant prohibitin ligands.
    Elderwish S; Audebrand A; Nebigil CG; Désaubry L
    Eur J Med Chem; 2020 Jan; 186():111859. PubMed ID: 31735574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrazole containing natural products: synthetic preview and biological significance.
    Kumar V; Kaur K; Gupta GK; Sharma AK
    Eur J Med Chem; 2013 Nov; 69():735-53. PubMed ID: 24099993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stopping trouble before it starts.
    Clardy J
    ACS Chem Biol; 2006 Feb; 1(1):17-9. PubMed ID: 17163634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplified silvestrol analogues with potent cytotoxic activity.
    Hawkins BC; Lindqvist LM; Nhu D; Sharp PP; Segal D; Powell AK; Campbell M; Ryan E; Chambers JM; White JM; Rizzacasa MA; Lessene G; Huang DC; Burns CJ
    ChemMedChem; 2014 Jul; 9(7):1556-66. PubMed ID: 24677741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-mediated sequestration of the RNA helicase eIF4A by Pateamine A inhibits translation initiation.
    Bordeleau ME; Cencic R; Lindqvist L; Oberer M; Northcote P; Wagner G; Pelletier J
    Chem Biol; 2006 Dec; 13(12):1287-95. PubMed ID: 17185224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms and anti-cancer aspects of the medicinal phytochemicals rocaglamides (=flavaglines).
    Li-Weber M
    Int J Cancer; 2015 Oct; 137(8):1791-9. PubMed ID: 24895251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antitumor activity of cyclodepsipeptide zygosporamide and its analogues.
    Wang Y; Zhang F; Zhang Y; Liu JO; Ma D
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4385-7. PubMed ID: 18606540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural glycoconjugates with antitumor activity.
    La Ferla B; Airoldi C; Zona C; Orsato A; Cardona F; Merlo S; Sironi E; D'Orazio G; Nicotra F
    Nat Prod Rep; 2011 Mar; 28(3):630-48. PubMed ID: 21120227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and SAR studies of marine natural products ma'edamines A, B and their analogues.
    Saha S; Reddy ChV; Xu S; Sankar S; Neamati N; Patro B
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5135-9. PubMed ID: 23927972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on Phytochemical and Biological Studies on Rocaglate Derivatives from Aglaia Species.
    Agarwal G; Chang LS; Soejarto DD; Kinghorn AD
    Planta Med; 2021 Oct; 87(12-13):937-948. PubMed ID: 33784769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.